Provincial Advisory Group (PAG)

A Provincial Advisory Group (PAG) is in place to provide advice to the Pharmaceutical Advisory Committee about operational issues, as well as to inform strategic and policy direction. PAG reports to the Pharmaceutical Advisory Committee through its Chair.

Input from PAG ensures that the pCODR drug review process, and the resulting recommendations, meet the needs of participating provinces/territories and cancer agencies for evidence-based recommendations that guide drug funding decisions. Issues brought forward by PAG may include considerations related to the implementation of recommendations, advice around consultation and information exchange, and information about emerging trends in the development and use of cancer drugs.

All members of the PAG must comply with the following:

• pCODR Provincial Advisory Group (PAG) Terms of Reference
  Last updated: June 2019

Membership

The PAG consists of appointed representatives from each of the participating provincial/territorial Ministries of Health and provincial cancer agencies.

Members